CAPABILITIES
Clinical
Antibody Development
Taking antibody therapeutics from discovery research into early development activities, then onto full clinical development is a highly specialist activity.
The 272BIO Translational Science and Clinical team have the capability to design, execute and analyse pharmacokinetic and pharmacodynamic (PKPD) studies to characterise lead antibody candidates in the most appropriate model systems, prior to in-depth safety and Proof of Concept efficacy testing. As part of a multi-disciplinary project team, the Translational Science and Clinical team work closely with our Research team, the CMC Manufacturing, Analytical and Formulation teams, and our Project Management group to co-ordinate and execute the later antibody development stages; from early development, into full development and through to registration.
